Cross-border purchase of medications and health care in a sample of residents of El Paso, Texas, and Ciudad Juarez, Mexico

Journal of the National Medical Association

Volumn 101, Issue 2, 2009, Pages 167-173

  Rivera, José O ^a,b,d   Ortiz, Melchor ^c   Cardenas, Victor ^c  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE   (United States)

Author keywords

Drugs; Health care; Health insurance; Mexican americans

Indexed keywords

ADULT; ARTICLE; DENTAL CARE; DRUG MARKETING; FEMALE; HEALTH CARE; HEALTH INSURANCE; HEALTH SERVICE; HEALTH SURVEY; HOSPITAL PURCHASING; HUMAN; INTERVIEW; MALE; MEDICAL CARE; MEXICO; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

EID: 65249119295     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30831-2     Document Type: Article

References (11)

1. University of Texas at El Paso Institute for Policy and Economic Development. Report prepared for the US / Mexico Border Counties Coalition, March 2006: http://www.bordercounties.org/ Accessed July 18, 2007.
2. Escobedo LG, Cardenas VM. Utilization and Purchase of Medical Care Services in Mexico by US Residents. Pan American J Pub Health. 2006; 19:300-305.
3. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162:199-200.
4. Macias EP, Morales LS. Crossing the border for health care. J Health Care Poor Underserved. 2001;12:77-87.
5. Casner PR, Guerra LG. Purchasing prescription medication in Mexico without a prescription. The experience at the border. West J Med. 1992; 156: 512-516.
6. Calvillo JP, Lai L. Pilot study of a survey of US residents purchasing medications in Mexico: demographics, reasons, and types of medications purchased. Clin Ther. 2003; 25:561-577.
7. Schwertner HA, Storrow AB. Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico. Clin Ther. 2005; 27:609-615.
8. Karlage KL, Myrdal PB. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study. Drug Dev Ind Pharm. 2005;31:993-1000.
9. Turner AN, Ellertson C, Thomas S, Garcia S. Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants. Sex Transm Infect. 2003:79:224-228.
10. Kroeger A, Ochoa H, Arana B, et al. Inadequate drug advice in the pharmacies of Guatemala and Mexico: the scale of the problem and explanatory factors. Ann Trap Med Parasitol. 2001 ;95: 605-616.
11. Bronzwaer SL, Cars O, Buchholz U, et al. European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8: 278-282.